Healthcare Stocks Thrive Amid Rate Hike Uncertainty
With rising bond yields and inflation above target, investors are bracing for further rate hikes from the Federal Reserve. This could make life more expensive for companies and consumers alike.
The healthcare sector appears less vulnerable to these dynamics, as people will continue to prioritize their health regardless of cost increases.
Eli Lilly, Medtronic, and Johnson & Johnson are three stocks in this sector that may be worth a closer look. Eli Lilly's success with GLP-1 weight-loss drugs has generated significant cash flow, allowing the company to diversify its pipeline through strategic acquisitions.
Medtronic is a low-risk turnaround story, having slimmed down its business and invested in new products. The company's sales growth accelerated to 8.4% in fiscal 2026, followed by an even stronger 14% increase in the first quarter of 2027.
Johnson & Johnson is a diversified Dividend King with a proven track record of success, having increased its dividend annually for over six decades.